Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. STLA
7. EC
8. ALNY
9. CNS
10. SPCX

Go back to Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
(NASDAQ: STOK) Delayed: 31.20 -0.42 (1.33%)
Previous Close $31.62    52 Week High $ 
Open $31.37    52 Week Low $ 
Day High $32.18    P/E N/A 
Day Low $30.58    EPS $ 
Volume 1,116,086